Item 8.01 Other Events.

On June 12, 2020, bluebird bio, Inc. ("bluebird") issued press releases announcing updated clinical data being presented at the Virtual Edition of the 25th Congress of the European Hematology Association from the HGB-206 clinical study in sickle cell disease, and the HGB-207 and HGB-212 clinical studies in transfusion-dependent beta-thalassemia. The full text of bluebird's press releases is filed as Exhibits 99.1 and 99.2 to this Current Report on Form 8-K and is incorporated herein by reference.

Item 9.01 Financial Statements and Exhibits.



(d) Exhibits
    Exhibit
      No.                                             Description
     99.1               Press release issued by bluebird bio, Inc. on June 12, 2020.
     99.2               Press release issued by bluebird bio, Inc. on June 12, 2020.
      104             Cover Page Interactive Data File (embedded within the Inline XBRL document)

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses